B. Lambert

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome

W. Sperl, B. Kofler, R. Feichtinger, 2017, Oncotarget.

A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

Max C. Richardson, Jun Yu Li, Kelly A. Fusco, 2022, Critical Care.

Keto-on-the-Clock: A Survey of Dietetic Care Contact Time Taken to Provide Ketogenic Diets for Drug-Resistant Epilepsy in the UK

N. Schoeler, K. Lightfoot, K. Martin-McGill, 2021, Nutrients.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Mitochondria: The ketogenic diet--A metabolism-based therapy.

W. Sperl, B. Kofler, R. Feichtinger, 2015, The international journal of biochemistry & cell biology.

A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects.

S. Neubauer, K. Clarke, C. Szmigielski, 2011, The American journal of clinical nutrition.

A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects 1 – 3

S. Neubauer, K. Clarke, C. Szmigielski, 2011 .

Understanding the core principles of a ‘modified ketogenic diet’: a UK and Ireland perspective

N. Schoeler, S. Wood, E. Neal, 2019, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

Max C. Richardson, Kelly A. Fusco, Troy H. Campbell, 2022, Intensive Care Medicine.

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy

S. Eaton, M. Walker, S. Sisodiya, 2021, Brain communications.